| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2500331 | Farmacia Hospitalaria | 2009 | 10 Pages |
Abstract
Use of a set combination of efavirenz, emtricitabine and tenofovir to treat adult patients with the HIV-1 virus would lead to slight surpluses or even budgetary savings by decreasing the number of daily doses, which could increase patients' quality of life and help them stay on the treatment properly.
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmaceutical Science
Authors
Itziar Oyagüez, Miguel A. Casado, Manuel Cotarelo, Antonio RamÃrez-Arellano, Josep Mallolas,